Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Addex Therapeutics (ADXN) Net Income - Minority (2022 - 2024)

Historic Net Income - Minority for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to -$11.0 million.

  • Addex Therapeutics' Net Income - Minority fell 75577.38% to -$11.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$11.0 million, marking a year-over-year decrease of 75577.38%. This contributed to the annual value of -$11.0 million for FY2024, which is 76280.7% down from last year.
  • Latest data reveals that Addex Therapeutics reported Net Income - Minority of -$11.0 million as of Q4 2024, which was down 75577.38% from -$1.3 million recorded in Q4 2023.
  • Over the past 5 years, Addex Therapeutics' Net Income - Minority peaked at -$1.3 million during Q4 2023, and registered a low of -$11.0 million during Q4 2024.
  • For the 3-year period, Addex Therapeutics' Net Income - Minority averaged around -$5.8 million, with its median value being -$5.1 million (2022).
  • Per our database at Business Quant, Addex Therapeutics' Net Income - Minority surged by 7468.88% in 2023 and then plummeted by 75577.38% in 2024.
  • Quarter analysis of 3 years shows Addex Therapeutics' Net Income - Minority stood at -$5.1 million in 2022, then surged by 74.69% to -$1.3 million in 2023, then crashed by 755.77% to -$11.0 million in 2024.
  • Its Net Income - Minority stands at -$11.0 million for Q4 2024, versus -$1.3 million for Q4 2023 and -$5.1 million for Q4 2022.